The most common adverse effects of adalimumab are:

- Injection site reactions

- Headache

- Rash

- Risk of serious infections, in particular, reactivation of latent tuberculosis.

- Other infections such as deep fungal infections, histoplasmosis, listeriosis, pulmonary aspergillosis, andÂ Pneumocystis jiroveci pneumonia may occur.

- Antibody development to adalimumab

- Elevated creatinine phosphokinase and transaminases

- Worsening or initiation of congestive heart failure

- Lupus-like syndrome

- Lymphoma

- Pancytopenia

- Worsening or initiation of multiple sclerosis/neurological disease.